Drugs / Optalgin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03529097 Comparator | Jun 2018 → Dec 2019 | urinary tract obstruction | Sheba Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Optalgin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03529097 ↗ |
| Route | Intravenous | “Oral and IV Optalgin” NCT03529097 ↗ |
| Route | Oral | “Oral and IV Optalgin” NCT03529097 ↗ |